BioSpace News Archive

BioMarin Pharmaceutical Inc. announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer, will present at Goldman Sachs 12th Annual Healthcare CEOs Unscripted: A View from the Top on January 9, 2020 at 8:45am ET in New York.

Therapeutics Solutions International, Inc., (OTC Markets: TSOI) reported today positive animal and human brain cell data demonstrating inhibition in microglial activation of IL-1 beta, IL-6, and TNF-a. NeuroStilbene was also shown to induce neurogenic growth factors and protected from peroxide and kainic-acid induced apoptosis.

New enterprise software platform brings data revolution to cement and concrete

The presentation will be webcast live at the aforementioned time, and archived for 30 days thereafter, via the Company’s website at www.rockwellmed.com, under the “Investors” section.

A key immune signal has a previously unknown role in turning off the immune system’s attack on pancreatic cancer cells, a new study finds.

KDx Diagnostics, Inc., announced that the Food and Drug Administration has granted “Breakthrough Device” designation for its URO17™ Bladder Cancer Recurrence Test.

Nasdaq Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement exists if the deficiency continues for a period of 30 consecutive business days.

A live webcast of the presentation can be viewed on the company’s website at www.stemline.com.

Corporate presentation by CEO Casey Lynch will be webcast live Lynch will also participate in a roundtable session earlier in the day

ADVANZ PHARMA Corp. Limited announced changes to its board of directors that are consistent with the Company’s previously disclosed strategic focus on Western Europe.